Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Shantharam Harish | Chief Financial Officer | 6 | $0 | $0 | 2024-03-22 |
| Dorling Janet | Director | 21 | $0 | $562.1K | 2024-03-22 |
| Wills Robert James | Director | 32 | $95.0K | $0 | 2024-03-22 |
| Lefebvre Eric | Director | 6 | $0 | $0 | 2024-03-22 |
| McWherter Charles | Sr. Vice President | 107 | $91.9K | $2.42M | 2024-03-22 |
| Shah Sujal | President & CEO | 83 | $555.7K | $3.25M | 2024-03-22 |
| Loewy Caroline M | Director | 20 | $0 | $0 | 2024-03-22 |
| Dickinson Klara | See Remarks | 18 | $0 | $0 | 2024-03-22 |
| Quinlan Paul T | General Counsel | 49 | $0 | $1.50M | 2024-03-22 |
| EMSTER KURT VON | Director | 60 | $1000.0K | $20.00M | 2024-03-22 |
| WIGGANS THOMAS G | Director | 8 | $0 | $0 | 2024-03-22 |
| Menold Daniel | Vice President, Finance | 41 | $0 | $1.03M | 2024-01-16 |
| Aghazadeh Behzad | 10% Owner | 7 | $35.00M | $3.1K | 2023-09-13 |
| KIM DENNIS D | Chief Medical Officer | 14 | $60.8K | $1.14M | 2023-04-17 |
| STUART LEWIS J | Chief Commercial Officer | 3 | $0 | $0 | 2023-01-25 |
| TRUEX PAUL F | Director | 8 | $0 | $0 | 2021-01-26 |
| von Emster Kurt | Director | 9 | $4.74M | $0 | 2020-05-15 |
| GOLDFISCHER CARL | Director | 32 | $0 | $584.8K | 2019-02-07 |
| Weiland Robert J. | Director | 6 | $0 | $0 | 2019-01-29 |
| STEIN EVAN A. | Director | 6 | $0 | $0 | 2019-01-29 |
| Booth Robert F. | Director | 5 | $0 | $0 | 2019-01-29 |
| Boudes Pol F | Chief Medical Officer | 7 | $0 | $0 | 2019-01-29 |
| OMara Patrick J. | VP, Business Development | 6 | $8.2K | $0 | 2018-01-24 |
| Martin Robert L. | Sr. Vice President | 5 | $0 | $0 | 2018-01-24 |
| Rosemark Kirk | V.P. Regulatory & Quality | 5 | $0 | $0 | 2017-01-19 |
| Van Wart Harold | President and CEO | 8 | $25.0K | $0 | 2017-01-19 |
| Kumar Hari | Director | 2 | $0 | $0 | 2015-06-24 |
| LANGE LOUIS G | Director | 2 | $0 | $0 | 2015-06-24 |
| PENHOET EDWARD | Director | 1 | $0 | $0 | 2015-01-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 80,000 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 88,351 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 39,375 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 50,000 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 47,916 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 90,000 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 621,101 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 146,875 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 314,120 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 536,032 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 284,712 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 649,999 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 800,000 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 357,500 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 9,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 18,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer deriv | 2024-03-22 | 2024-03-22 | 107,000 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer deriv | 2024-03-22 | 2024-03-22 | 233,176 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer deriv | 2024-03-22 | 2024-03-22 | 105,625 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer deriv | 2024-03-22 | 2024-03-22 | 215,000 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer deriv | 2024-03-22 | 2024-03-22 | 22,167 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 138,312 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 175,000 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 66,500 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 328,299 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 215,000 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 100,000 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 200,000 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 78,000 | — | $0 | 0 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 74,750 | — | $0 | 0 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | D To issuer deriv | 2024-03-22 | 2024-03-22 | 360,000 | — | $0 | 0 | SEC↗ |
| Dorling Janet | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| Dorling Janet | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| Dorling Janet | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| Dorling Janet | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 55,000 | — | $0 | 0 | SEC↗ |
| Lefebvre Eric | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| Lefebvre Eric | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| Lefebvre Eric | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 115,000 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 172,891 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 300,000 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 225,000 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 112,000 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 328,299 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 118,625 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 146,875 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 97,222 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 44,084 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 51,750 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer deriv | 2024-03-22 | 2024-03-22 | 91,666 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 14,010 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 16,000 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 27,705 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 49,245 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 7,500 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 30,000 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 25,000 | — | $0 | 0 | SEC↗ |
| Loewy Caroline M | Director | D To issuer deriv | 2024-03-22 | 2024-03-22 | 67,000 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | D To issuer | 2024-03-22 | 2024-03-22 | 90,000 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer | 2024-03-22 | 2024-03-22 | 96,250 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | D To issuer | 2024-03-22 | 2024-03-22 | 310,420 | — | $0 | 0 | SEC↗ |
| Wills Robert James | Director | D To issuer | 2024-03-22 | 2024-03-22 | 30,000 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer | 2024-03-22 | 2024-03-22 | 41,824 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | D To issuer | 2024-03-22 | 2024-03-22 | 28,438 | — | $0 | 0 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | D To issuer | 2024-03-22 | 2024-03-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | D To issuer | 2024-03-22 | 2024-03-22 | 20,125 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer | 2024-03-22 | 2024-03-22 | 31,938 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | D To issuer | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2024-03-13 | 2024-03-15 | 41,824 | — | $0 | 8,872 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 18,899 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 11,649 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 2,288 | — | $0 | 12,845 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 22,076 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 14,372 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 3,125 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 1 | — | $0 | 35,799 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 52,084 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 14,625 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2024-03-13 | 2024-03-15 | 41,824 | $7.89 | $330.0K | 70,262 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 18,899 | $9.21 | $174.1K | 364,808 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 52,084 | $1.72 | $89.6K | 345,909 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 14,625 | $1.06 | $15.5K | 293,825 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 11,649 | $10.00 | $116.5K | 279,200 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 14,372 | $8.43 | $121.2K | 382,305 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 22,076 | $4.05 | $89.4K | 404,381 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 2,288 | $5.78 | $13.2K | 406,669 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 1 | $2.94 | $3 | 406,670 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2024-03-13 | 2024-03-15 | 3,125 | $11.69 | $36.5K | 367,933 | SEC↗ |
| Dorling Janet | Director | M Exercise deriv | 2024-02-12 | 2024-02-14 | 6,000 | — | $0 | 55,000 | SEC↗ |
| Dorling Janet | Director | S Sale | 2024-02-12 | 2024-02-14 | 6,000 | $31.97 | $191.8K | 0 | SEC↗ |
| Dorling Janet | Director | M Exercise | 2024-02-12 | 2024-02-14 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| EMSTER KURT VON | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| Lefebvre Eric | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| Loewy Caroline M | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| Dorling Janet | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| Wills Robert James | Director | A Award deriv | 2024-01-24 | 2024-01-26 | 14,010 | — | $0 | 14,010 | SEC↗ |
| Shah Sujal | Chief Executive Officer | A Award deriv | 2024-01-24 | 2024-01-26 | 357,500 | — | $0 | 357,500 | SEC↗ |
| Quinlan Paul T | General Counsel | A Award deriv | 2024-01-24 | 2024-01-26 | 105,625 | — | $0 | 105,625 | SEC↗ |
| McWherter Charles | President of R&D | A Award deriv | 2024-01-24 | 2024-01-26 | 118,625 | — | $0 | 118,625 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | A Award deriv | 2024-01-24 | 2024-01-26 | 78,000 | — | $0 | 78,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2024-01-24 | 2024-01-26 | 74,750 | — | $0 | 74,750 | SEC↗ |
| Shah Sujal | Chief Executive Officer | A Award | 2024-01-24 | 2024-01-26 | 96,250 | — | $0 | 267,551 | SEC↗ |
| Quinlan Paul T | General Counsel | A Award | 2024-01-24 | 2024-01-26 | 28,438 | — | $0 | 28,438 | SEC↗ |
| McWherter Charles | President of R&D | A Award | 2024-01-24 | 2024-01-26 | 31,938 | — | $0 | 46,938 | SEC↗ |
| Dickinson Klara | Chief Regulatory Officer | A Award | 2024-01-24 | 2024-01-26 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award | 2024-01-24 | 2024-01-26 | 20,125 | — | $0 | 20,125 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2024-01-19 | 2024-01-22 | 8,334 | — | $0 | 91,666 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2024-01-19 | 2024-01-22 | 3,125 | — | $0 | 146,875 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2024-01-19 | 2024-01-22 | 2,250 | — | $0 | 51,750 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2024-01-19 | 2024-01-22 | 1,916 | — | $0 | 44,084 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2024-01-19 | 2024-01-22 | 2,778 | — | $0 | 97,222 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2024-01-19 | 2024-01-22 | 2,250 | $23.67 | $53.3K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2024-01-19 | 2024-01-22 | 2,778 | $1.72 | $4.8K | 17,778 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2024-01-19 | 2024-01-22 | 2,778 | $23.66 | $65.7K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2024-01-19 | 2024-01-22 | 1,916 | $1.82 | $3.5K | 16,916 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2024-01-19 | 2024-01-22 | 2,250 | $1.06 | $2.4K | 17,250 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2024-01-19 | 2024-01-22 | 8,334 | $10.00 | $83.3K | 23,334 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2024-01-19 | 2024-01-22 | 8,334 | $23.68 | $197.3K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2024-01-19 | 2024-01-22 | 3,125 | $11.69 | $36.5K | 18,125 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2024-01-19 | 2024-01-22 | 3,125 | $23.68 | $74.0K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2024-01-19 | 2024-01-22 | 1,916 | $23.66 | $45.3K | 15,000 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2024-01-16 | 2024-01-16 | 5,000 | — | $0 | 107,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2024-01-16 | 2024-01-16 | 10,000 | — | $0 | 135,109 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2024-01-16 | 2024-01-16 | 5,000 | $23.58 | $117.9K | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2024-01-16 | 2024-01-16 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2024-01-16 | 2024-01-16 | 10,000 | $23.58 | $235.8K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2024-01-16 | 2024-01-16 | 10,000 | $4.05 | $40.5K | 10,000 | SEC↗ |
| Dorling Janet | Director | M Exercise deriv | 2024-01-10 | 2024-01-10 | 6,000 | — | $0 | 61,000 | SEC↗ |
| Dorling Janet | Director | M Exercise | 2024-01-10 | 2024-01-10 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| Dorling Janet | Director | S Sale | 2024-01-10 | 2024-01-10 | 6,000 | $23.86 | $143.2K | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-12-18 | 2023-12-18 | 6,504 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-12-18 | 2023-12-18 | 704 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-12-18 | 2023-12-18 | 3,890 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-12-18 | 2023-12-18 | 234 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-12-18 | 2023-12-18 | 6,504 | $21.48 | $139.7K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-12-18 | 2023-12-18 | 6,504 | $5.00 | $32.5K | 21,504 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-12-18 | 2023-12-18 | 4,828 | $21.49 | $103.8K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-12-18 | 2023-12-18 | 4,828 | $5.00 | $24.1K | 19,828 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-12-15 | 2023-12-15 | 5,000 | — | $0 | 112,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-12-15 | 2023-12-15 | 11,497 | — | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-12-15 | 2023-12-15 | 10,000 | — | $0 | 145,109 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-12-15 | 2023-12-15 | 5,000 | $21.98 | $109.9K | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-12-15 | 2023-12-15 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-12-15 | 2023-12-15 | 10,000 | $4.05 | $40.5K | 10,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-12-15 | 2023-12-15 | 11,497 | $21.99 | $252.8K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-12-15 | 2023-12-15 | 10,000 | $21.98 | $219.8K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-12-15 | 2023-12-15 | 11,497 | $8.43 | $96.9K | 11,497 | SEC↗ |
| Dorling Janet | Director | M Exercise deriv | 2023-12-11 | 2023-12-11 | 6,000 | — | $0 | 67,000 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-12-11 | 2023-12-11 | 12,973 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-12-11 | 2023-12-11 | 20,856 | — | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-12-11 | 2023-12-11 | 31,036 | — | $0 | 0 | SEC↗ |
| Dorling Janet | Director | M Exercise | 2023-12-11 | 2023-12-11 | 6,000 | $4.63 | $27.8K | 6,000 | SEC↗ |
| Dorling Janet | Director | S Sale | 2023-12-11 | 2023-12-11 | 6,000 | $20.07 | $120.4K | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2023-12-11 | 2023-12-11 | 890 | $5.00 | $4.5K | 172,191 | SEC↗ |
| Shah Sujal | Chief Executive Officer | S Sale | 2023-12-11 | 2023-12-11 | 890 | $20.81 | $18.5K | 171,301 | SEC↗ |
| Shah Sujal | Chief Executive Officer | S Sale | 2023-12-11 | 2023-12-11 | 63,975 | $19.99 | $1.28M | 171,301 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2023-12-11 | 2023-12-11 | 63,975 | $5.00 | $319.9K | 235,276 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-11-17 | 2023-11-17 | 6,506 | — | $0 | 6,504 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-11-17 | 2023-11-17 | 708 | — | $0 | 704 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-11-17 | 2023-11-17 | 236 | — | $0 | 234 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-11-17 | 2023-11-17 | 3,892 | — | $0 | 3,890 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-11-17 | 2023-11-17 | 11,342 | $18.28 | $207.3K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-11-17 | 2023-11-17 | 11,342 | $5.00 | $56.7K | 26,342 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-11-15 | 2023-11-17 | 5,000 | — | $0 | 117,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-11-15 | 2023-11-17 | 17,500 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-11-15 | 2023-11-17 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-11-15 | 2023-11-17 | 5,000 | $17.38 | $86.9K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-11-15 | 2023-11-17 | 17,500 | $3.45 | $60.4K | 17,500 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-11-15 | 2023-11-17 | 0 | $17.38 | $0 | 0 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-11-13 | 2023-11-14 | 31,036 | — | $0 | 31,036 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-11-13 | 2023-11-14 | 12,972 | — | $0 | 12,973 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-11-13 | 2023-11-14 | 20,855 | — | $0 | 20,856 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2023-11-13 | 2023-11-14 | 20,855 | $5.00 | $104.3K | 192,156 | SEC↗ |
| Shah Sujal | Chief Executive Officer | S Sale | 2023-11-13 | 2023-11-14 | 20,855 | $15.89 | $331.4K | 171,301 | SEC↗ |
| Shah Sujal | Chief Executive Officer | S Sale | 2023-11-13 | 2023-11-14 | 44,008 | $15.89 | $699.3K | 171,301 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2023-11-13 | 2023-11-14 | 44,008 | $5.00 | $220.0K | 215,309 | SEC↗ |
| Dorling Janet | Director | M Exercise deriv | 2023-11-10 | 2023-11-14 | 7,000 | — | $0 | 73,000 | SEC↗ |
| Dorling Janet | Director | S Sale | 2023-11-10 | 2023-11-14 | 7,000 | $15.24 | $106.7K | 0 | SEC↗ |
| Dorling Janet | Director | M Exercise | 2023-11-10 | 2023-11-14 | 7,000 | $4.63 | $32.4K | 7,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-10-18 | 2023-10-18 | 236 | — | $0 | 470 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-10-18 | 2023-10-18 | 3,892 | — | $0 | 7,782 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-10-18 | 2023-10-18 | 10,401 | — | $0 | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-10-18 | 2023-10-18 | 708 | — | $0 | 1,412 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-10-18 | 2023-10-18 | 6,506 | — | $0 | 13,010 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-10-18 | 2023-10-18 | 21,743 | $14.07 | $305.9K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-10-18 | 2023-10-18 | 21,743 | $5.00 | $108.7K | 36,743 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-10-16 | 2023-10-18 | 5,000 | — | $0 | 122,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-10-16 | 2023-10-18 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-10-16 | 2023-10-18 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-10-16 | 2023-10-18 | 5,000 | $13.76 | $68.8K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-10-16 | 2023-10-18 | 0 | $13.76 | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-10-16 | 2023-10-18 | 17,500 | $3.45 | $60.4K | 17,500 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-10-09 | 2023-10-10 | 12,972 | — | $0 | 25,945 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-10-09 | 2023-10-10 | 20,855 | — | $0 | 41,711 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise deriv | 2023-10-09 | 2023-10-10 | 31,034 | — | $0 | 62,072 | SEC↗ |
| Shah Sujal | Chief Executive Officer | M Exercise | 2023-10-09 | 2023-10-10 | 64,861 | $5.00 | $324.3K | 236,162 | SEC↗ |
| Shah Sujal | Chief Executive Officer | S Sale | 2023-10-09 | 2023-10-10 | 64,861 | $14.20 | $921.0K | 171,301 | SEC↗ |
| EMSTER KURT VON | Director | M Exercise deriv | 2023-09-29 | 2023-09-29 | 943 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | M Exercise deriv | 2023-09-29 | 2023-09-29 | 3,372 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | M Exercise deriv | 2023-09-29 | 2023-09-29 | 5,249 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | M Exercise deriv | 2023-09-29 | 2023-09-29 | 6,357 | — | $0 | 0 | SEC↗ |
| EMSTER KURT VON | Director | S Sale | 2023-09-29 | 2023-09-29 | 15,921 | $15.68 | $249.6K | 90,000 | SEC↗ |
| EMSTER KURT VON | Director | M Exercise | 2023-09-29 | 2023-09-29 | 15,921 | $5.00 | $79.6K | 105,921 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-09-18 | 2023-09-19 | 3,892 | — | $0 | 11,674 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-09-18 | 2023-09-19 | 10,404 | — | $0 | 10,401 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-09-18 | 2023-09-19 | 708 | — | $0 | 2,120 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-09-18 | 2023-09-19 | 236 | — | $0 | 706 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-09-18 | 2023-09-19 | 6,506 | — | $0 | 19,516 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-09-18 | 2023-09-19 | 21,746 | $16.22 | $352.7K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-09-18 | 2023-09-19 | 21,746 | $5.00 | $108.7K | 36,746 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-09-15 | 2023-09-19 | 53,000 | — | $0 | 127,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-09-15 | 2023-09-19 | 15,000 | — | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-09-15 | 2023-09-19 | 1,545 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-09-15 | 2023-09-19 | 24,000 | $2.94 | $70.6K | 24,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-09-15 | 2023-09-19 | 5,000 | $16.87 | $84.3K | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-09-15 | 2023-09-19 | 24,000 | $2.94 | $70.6K | 24,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-09-15 | 2023-09-19 | 24,000 | $16.87 | $404.9K | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-09-15 | 2023-09-19 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-09-15 | 2023-09-19 | 24,000 | $16.87 | $404.9K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-09-15 | 2023-09-19 | 0 | $16.87 | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-09-15 | 2023-09-19 | 15,000 | $1.72 | $25.8K | 15,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-09-15 | 2023-09-19 | 0 | $16.87 | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-09-15 | 2023-09-19 | 1,545 | $1.82 | $2.8K | 1,545 | SEC↗ |
| Aghazadeh Behzad | 10% Owner | S Sale deriv | 2023-09-13 | 2023-09-14 | 250 | $0.98 | $245 | 250 | SEC↗ |
| Aghazadeh Behzad | 10% Owner | S Sale deriv | 2023-09-13 | 2023-09-14 | 950 | $1.10 | $1.0K | 950 | SEC↗ |
| Aghazadeh Behzad | 10% Owner | S Sale deriv | 2023-09-12 | 2023-09-14 | 300 | $1.00 | $300 | 300 | SEC↗ |
| Aghazadeh Behzad | 10% Owner | S Sale deriv | 2023-09-12 | 2023-09-14 | 1,500 | $1.00 | $1.5K | 1,500 | SEC↗ |
| Aghazadeh Behzad | 10% Owner | P Buy deriv | 2023-09-12 | 2023-09-14 | 583,771 | $17.13 | $10.00M | 583,771 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-08-18 | 2023-08-18 | 708 | — | $0 | 2,828 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-08-18 | 2023-08-18 | 6,506 | — | $0 | 26,022 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-08-18 | 2023-08-18 | 3,892 | — | $0 | 15,566 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-08-18 | 2023-08-18 | 236 | — | $0 | 942 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-08-18 | 2023-08-18 | 10,404 | — | $0 | 20,805 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-08-18 | 2023-08-18 | 21,746 | $5.00 | $108.7K | 36,746 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-08-18 | 2023-08-18 | 21,746 | $11.47 | $249.4K | 15,000 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-08-15 | 2023-08-16 | 5,000 | — | $0 | 180,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-08-15 | 2023-08-16 | 8,500 | — | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-08-15 | 2023-08-16 | 7,000 | — | $0 | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-08-15 | 2023-08-16 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-08-15 | 2023-08-16 | 5,000 | $11.91 | $59.5K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-08-15 | 2023-08-16 | 0 | $11.92 | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-08-15 | 2023-08-16 | 7,000 | $10.00 | $70.0K | 7,000 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-08-15 | 2023-08-16 | 0 | $12.13 | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-08-15 | 2023-08-16 | 8,500 | $1.06 | $9.0K | 8,500 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-08-09 | 2023-08-11 | 6,486 | — | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise deriv | 2023-08-09 | 2023-08-11 | 14,459 | — | $0 | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | S Sale | 2023-08-09 | 2023-08-11 | 20,945 | $12.35 | $258.7K | 0 | SEC↗ |
| Menold Daniel | Vice President, Finance | M Exercise | 2023-08-09 | 2023-08-11 | 20,945 | $5.00 | $104.7K | 20,945 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-07-18 | 2023-07-19 | 6,506 | — | $0 | 32,528 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-07-18 | 2023-07-19 | 3,892 | — | $0 | 19,458 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-07-18 | 2023-07-19 | 708 | — | $0 | 3,536 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-07-18 | 2023-07-19 | 10,407 | — | $0 | 31,209 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-07-18 | 2023-07-19 | 236 | — | $0 | 1,178 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-07-18 | 2023-07-19 | 21,749 | $11.43 | $248.6K | 15,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-07-18 | 2023-07-19 | 21,749 | $5.00 | $108.7K | 36,749 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-07-14 | 2023-07-14 | 5,000 | — | $0 | 185,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-07-14 | 2023-07-14 | 5,000 | $11.81 | $59.0K | 0 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-07-14 | 2023-07-14 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise deriv | 2023-06-30 | 2023-06-30 | 5,000 | — | $0 | 190,000 | SEC↗ |
| Quinlan Paul T | General Counsel | M Exercise | 2023-06-30 | 2023-06-30 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| Quinlan Paul T | General Counsel | S Sale | 2023-06-30 | 2023-06-30 | 5,000 | $10.05 | $50.3K | 0 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-06-20 | 2023-06-21 | 10,407 | — | $0 | 41,616 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-06-20 | 2023-06-21 | 3,892 | — | $0 | 23,350 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-06-20 | 2023-06-21 | 236 | — | $0 | 1,414 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-06-20 | 2023-06-21 | 708 | — | $0 | 4,244 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-06-20 | 2023-06-21 | 6,506 | — | $0 | 39,034 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise | 2023-06-20 | 2023-06-21 | 21,749 | $5.00 | $108.7K | 36,749 | SEC↗ |
| McWherter Charles | President of R&D | S Sale | 2023-06-20 | 2023-06-21 | 21,749 | $8.16 | $177.5K | 15,000 | SEC↗ |
| Shantharam Harish | Chief Financial Officer | A Award deriv | 2023-05-22 | 2023-05-22 | 360,000 | — | $0 | 360,000 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-05-18 | 2023-05-19 | 10,407 | — | $0 | 52,023 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-05-18 | 2023-05-19 | 236 | — | $0 | 1,650 | SEC↗ |
| McWherter Charles | President of R&D | M Exercise deriv | 2023-05-18 | 2023-05-19 | 3,892 | — | $0 | 27,242 | SEC↗ |